Feature Channels: Kidney Disease

Filters close
Released: 13-Dec-2023 2:20 PM EST
WFIRM and Partnering Institutions Awarded Five-Year, $6 Million Grant on Kidney, Urology, and Hematology Research
Wake Forest Institute for Regenerative Medicine

The Wake Forest Institute for Regenerative Medicine (WFIRM) has received a $6 million grant from the National Institute for Diabetes, Digestive and Kidney Diseases, part of the National Institutes of Health.

Released: 13-Dec-2023 10:05 AM EST
Kidney disease linked to increased mortality after stroke thrombolysis
Wolters Kluwer Health: Lippincott

Renal dysfunction, especially chronic kidney disease, is the biggest risk factor of mortality among thrombolysed stroke patients, according to a retrospective cohort observational study published in Medicine®, a journal published in the Lippincott portfolio by Wolters Kluwer.

Released: 12-Dec-2023 9:00 AM EST
A Lifesaving Chain, A Global First: Penn Medicine Sets a Worldwide Record with 100 Kidney Paired Donation Transplants in a Year
Perelman School of Medicine at the University of Pennsylvania

For thousands of people around the world waiting for a kidney, paired exchange serves as a beacon of hope. One person's willingness to undergo the act of Kidney Paired Donation (KPD) often sets in motion a chain of beautiful and selfless acts, where individuals give and receive the chance for a better life.

Not for public release

This news release is embargoed until 11-Dec-2023 5:00 PM EST Released to reporters: 5-Dec-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 11-Dec-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 8-Dec-2023 1:05 PM EST
Study reveals insights into tacking diabetic kidney disease - with a side order of how anti-obesity drugs work
Monash University

Data from Australian researchers could partly explain why a trial of a new drug for diabetes, was recently halted because it was found to be so effective. Importantly, the data also reveals how anti-obesity drugs like Ozempic, actually work, which to date have been a mystery.

Released: 7-Dec-2023 2:15 PM EST
Looking for unique stories about the winter holidays? Check out the Winter Holidays channel
Newswise

It's the moooost wonderful time...of the year! Are you looking for new story ideas that are focused on the winter holiday season? Perhaps you're working on a story on on managing stress and anxiety? Perhaps you're working on a story on seasonal affective disorder? Or perhaps your editor asked you to write a story on tracking Santa? Look no further. Check out the Winter Holidays channel.

       
Released: 5-Dec-2023 5:05 PM EST
Eye scans provide crucial insights into kidney health, study finds
University of Edinburgh

3D eye scans can reveal vital clues about kidney health that could help to track the progression of disease, research suggests. The advance could revolutionise monitoring of kidney disease, which often progresses without symptoms in the early stages. Experts say the technology has potential to support early diagnosis as current screening tests cannot detect the condition until half of the kidney function has been lost.

Not for public release

This news release is embargoed until 4-Dec-2023 5:00 PM EST Released to reporters: 28-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 4-Dec-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Genetic Testing Saves Young Mom from Life-threatening Kidney Cancer
Released: 29-Nov-2023 10:05 AM EST
Genetic Testing Saves Young Mom from Life-threatening Kidney Cancer
Loyola Medicine

Genetic testing can be lifesaving for patients with increased risk of certain cancers, not just for themselves but also for other members of their family.

Not for public release

This news release is embargoed until 27-Nov-2023 5:00 PM EST Released to reporters: 20-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 27-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: After Multiple Organ Transplants, Grateful for 25 Extra Years
Released: 22-Nov-2023 10:05 AM EST
After Multiple Organ Transplants, Grateful for 25 Extra Years
Cedars-Sinai

This Thanksgiving marks a little more than 25 years since Christine Galan became the first person in the Western U.S. to have a combined organ transplant (heart and liver), and nearly five years since she returned to Cedars-Sinai for another organ transplant—this time, a kidney.

Newswise: Hackensack Meridian Children’s Health Medical Director of Pediatric Kidney Transplant Appointed as Co-Chair of National Kidney Transplant Working Group
Released: 16-Nov-2023 3:05 PM EST
Hackensack Meridian Children’s Health Medical Director of Pediatric Kidney Transplant Appointed as Co-Chair of National Kidney Transplant Working Group
Hackensack Meridian Health

Namrata G. Jain, MD, medical director of Pediatric Kidney Transplant at Joseph M. Sanzari Children’s Hospital at Hackensack University Medical Center, and associate professor of Pediatrics at Hackensack Meridian School of Medicine, has been appointed co-chair of the Transplant Working Group of the prestigious Pediatric Nephrology Research Consortium (PNRC).

Released: 10-Nov-2023 4:05 PM EST
Trial generates promising results for obinutuzumab in patients with lupus nephritis
Wiley

Obinutuzumab preserved kidney function, prevented flares in lupus nephritis trial.

Released: 8-Nov-2023 2:05 PM EST
Jana Care, Inc. Announces Initial Closing of a $6 Million Financing Round to Complete Commercialization of its Self-administered Blood Tests for Kidney and Heart Disease
Jana Care

Jana Care has secured funding to expand its at-home testing platform for chronic kidney and heart disease management.

30-Oct-2023 9:00 AM EDT
Real-World Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients
American Society of Nephrology (ASN)

Compared with kidney transplant recipients who did not receive sodium-glucose cotransporter-2 inhibitors, those treated with the medications had lower risks of experiencing kidney transplant failure, kidney transplant rejection, major adverse cardiac events, all-cause mortality, and genitourinary infections.

30-Oct-2023 9:00 AM EDT
County-Level Structural Racism May Affect Mortality Rates in People with Kidney Failure
American Society of Nephrology (ASN)

In a recent analysis of US data, Black patients with kidney failure experienced survival advantages compared with White patients when county-level structural racism was low, but they experienced survival disadvantages compared with White patients at higher levels of structural racism.

30-Oct-2023 9:00 AM EDT
Scientists Create the Most Complete Atlas of the Human Fetal Kidney to Date
American Society of Nephrology (ASN)

By examining the gene expression patterns of single cells from human fetal kidneys, researchers created a map that demonstrates the trajectories of cell states in the developing kidney and that identifies characteristics associated with kidney diseases.

30-Oct-2023 9:00 AM EDT
Are Results From Clinical Trials in Kidney Transplant Recipients Applicable to the Real World?
American Society of Nephrology (ASN)

Investigators have found demographic differences between participants of kidney transplant clinical trials and transplant recipients in the United States, even in recent years.

30-Oct-2023 9:00 AM EDT
Sotagliflozin Protects Kidney and Heart in Patients with Type 2 Diabetes and Chronic Kidney Disease
American Society of Nephrology (ASN)

Results from the phase 3 SCORED trial indicate that sotagliflozin protects kidney and heart health in individuals with type 2 diabetes and chronic kidney disease.



close
2.24796